Safety and effectiveness of Thulium VapoEnucleation of the prostate (ThuVEP) in patients on anticoagulant therapy

World Journal of Urology

Volumn 32, Issue 1, 2014, Pages 165-172

  Netsch, Christopher ^a   Stoehrer, M ^b   Bruning M ^b   Gabuev, A ^b   Bach, T ^a,c   Herrmann, T R W ^b   Gross, A J ^a  

^a ASKLEPIOS HOSPITAL BARMBEK   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Asklepios Klinik Harburg   (Germany)

Author keywords

Anticoagulants; Benign prostatic obstruction (BPO); Revolix; ThuVEP; Tm:YAG; VapoEnucleation

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; DRUG DERIVATIVE; THULIUM; TICLOPIDINE;

AGED; ARTICLE; BLEEDING; HUMAN; INCIDENCE; MALE; METHODOLOGY; MINIMALLY INVASIVE SURGERY; ORAL DRUG ADMINISTRATION; PROSTATE HYPERTROPHY; PROSTATECTOMY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; URINARY TRACT INFECTION; VEIN THROMBOSIS;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ASPIRIN; HEMORRHAGE; HUMANS; INCIDENCE; MALE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, MINIMALLY INVASIVE; THULIUM; TICLOPIDINE; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; VENOUS THROMBOSIS;

EID: 84893709851     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-013-1093-4     Document Type: Article

References (30)

1. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG, Urology Section of the Bavarian Working Group for Quality Assurance (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10, 654 patients. J Urol 180: 246-249.
2. Bell CR, Murdock PJ, Pasi KJ, Morgan RJ (1999) Thrombotic risk factors associated with transurethral prostatectomy. BJU Int 83: 984-989.
3. van Arsdalen KN, Barnes RW, Clarke G, Smith MJ, Koontz WW Jr (1983) Deep vein thrombosis and prostatectomy. Urology 21: 461-463.
4. Parr NJ, Loh CS, Desmond AD (1989) Transurethral resection of the prostate and bladder tumor without withdrawal of warfarin therapy. Br J Urol 64: 623-625.
5. Chakravarti A, MacDermott S (1998) Transurethral resection of the prostate in the anticoagulated patient. Br J Urol 81: 520-522.
6. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T (2005) High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol 173: 158-160.
7. Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58: 384-397.
8. Elzayat E, Habib E, Elhilali M (2006) Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol 175: 1428-1432.
9. Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, Sulser T, Bachmann A (2007) Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients with ongoing anticoagulation. Eur Urol 51: 1031-1038.
10. Bach T, Netsch C, Haecker A, Michel MS, Herrmann TR, Gross AJ (2010) Thulium: YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol 28: 39-43.
11. Bach T, Netsch C, Pohlmann L, Herrmann TR, Gross AJ (2011) Thulium: YAG vapoenucleation in large volume prostates. J Urol 186: 2323-2327.
12. Descazeaud A, Robert G, Azzousi AR, Ballereau C, Lukacs B, Haillot O, Dumonceau O, Devonec M, Fourmarier M, Saussine C, de la Taille A, Committee for lower urinary tract symptoms of the French Association of Urology (2009) Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review. BJU Int 103: 1162-1165.
13. Dotan ZA, Mor Y, Leibovitch I, Varon D, Golomb J, Duvdevani M, Ramon J (2002) The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol 168: 610-613.
14. Taylor K, Filgate R, Guo DY, Macneil F (2011) A retrospective study to assess the morbidity associated with transurethral prostatectomy in patients on antiplatelet or anticoagulant drugs. BJU Int 108(Suppl 2): 45.
15. Raj MD, McDonald C, Brooks AJ, Drummond M, Lau HM, Patel MI, Bariol SV, Wang AC, Woo HH (2011) Stopping anticoagulation before TURP does not appear to increase perioperative cardiovascular complications. Urology 78: 1380-1384.
16. Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH (2007) Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates > 100 ml. BJU Int 100: 593-598.
17. Pfitzenmaier J, Gilfrich C, Pritsch M, Herrmann D, Buse S, Haferkamp A, Djakovic N, Pahernik S, Hohenfellner M (2008) Vaporization of prostates of > or = 80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of < 80 mL. BJU Int 102: 332-337.
18. Pedraza R, Samadi A, Eshghi M (2004) Holmium laser enucleation of the prostate in critically ill patients with technique modification. J Endourol 18: 795-798.
19. Yuan J, Wang H, Wu G, Liu H, Zhang Y, Yang L (2008) Highpower (80 W) potassium titanyl phosphate laser prostatectomy in 128 high-risk patients. Postgrad Med J 84: 46-49.
20. Sandhu JS, Ng CK, Gonzalez RR, Kaplan SA, Te AE (2005) Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 19: 1196-1198.
21. Tyson MD, Lerner LB (2009) Safety of holmium laser enucleation of the prostate in anticoagulated patients. J Endourol 223: 1343-1346.
22. Chung DE, Wysock JS, Lee RK, Melamed SR, Kaplan SA, Te AE (2011) Outcomes and complications After 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. J Urol 186: 977-981.
23. Woo HH, Hossack TA (2011) Photoselective vaporization of the prostate with the 120-W lithium triborate laser in men taking coumadin. Urology 78: 142-145.
24. Sohn JH, Choi YS, Kim SJ, Cho HJ, Hong SH, Lee JY, Hwang TK, Kim SW (2011) Effectiveness and safety of photoselective vaporization of the prostate with the 120 W HPS greenlight laser in benign prostatic hyperplasia patients taking oral anticoagulants. Korean J Urol 52: 178-183.
25. Hauser S, Rogenhofer S, Ellinger J, Strunk T, Müller SC, Fechner G (2012) Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage. Urol Int 88: 390-394.
26. Tinmouth WW, Habib E, Kim SC, Kuo RL, Paterson RF, Terry CL, Elhilali M, Lingeman JE (2005) Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection? J Endourol 19: 550-554.
27. Martin AD, Nunez RN, Humphreys MR (2011) Bleeding after holmium laser enucleation of the prostate: lessons learned the hard way. BJU Int 107: 433-437.
28. Bach T, Muschter R, Sroka R, Gravas S, Skolarikos A, Herrmann TR, Bayer T, Knoll T, Abbou CC, Janetschek G, Bachmann A, Rassweiler JJ (2012) Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 61: 317-325.
29. Shah HN, Mahajan AP, Hegde SS, Bansal MB (2007) Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int 100: 94-101.
30. Mamoulakis C, Efthimiou I, Kazoulis S, Christoulakis I, Sofras F (2011) The modified Clavien classification system: a standardized platform for reporting complications in transurethral resection of the prostate. World J Urol 29: 205-210.